297
Participants
Start Date
June 14, 2010
Primary Completion Date
September 12, 2011
Study Completion Date
September 12, 2011
CP-601,927
CP-601,927 1-2 mg twice per day, oral 1 mg tablets, for 6 weeks.
Placebo
Matching placebo tablets, taken orally, twice per day, for 6 weeks.
Montefiore Medical Center, The Bronx
Social Psychiatry Research Institute, Brooklyn
Comprehensive NeuroScience, Inc., Fresh Meadows
Erie County Medical Center / State University of New York at Buffalo affiliate, Buffalo
Lehigh Valley Health Network, Allentown
City Line Family Medicine, Bala-Cynwyd
Suburban Research Associates, Media
University of Pennsylvania / Department of Psychiatry, Philadelphia
Frankford Avenue Family Practice, PC, Philadelphia
University of Virginia Health System / Department of Psychiatry and Neurobehavioral Sciences, Charlottesville
Mcguire Hall Annex, Richmond
Nelson Clinic, Richmond
Carolina Clinical Research Service LLC, Columbia
Atlanta Center for Medical Research, Atlanta
Atlanta Institute of Medicine and Research, Atlanta
Clinical Neuroscience Solutions, Inc., Jacksonville
Florida Clinical Research Center, LLC, Maitland
Clinical Neuroscience Solutions, Inc., Orlando
Comprehensive NeuroScience, Inc., St. Petersburg
Kettlie Joseph Daniels, MD, Inc., Toledo
Neurology and Neuroscience Center of Ohio, Toledo
Midwest Clinical Research Center, Dayton
Goldpoint Clinical Research, LLC, Indianapolis
Clinco, Terre Haute
Detroit Bio-Medical Laboratories, Inc., Rochester Hills
Rochester Center for Behavioral Medicine, Rochester Hills
Northbrooke Research Center, Brown Deer
Dean Foundation for Health, Research and Education, Middleton
Psychiatric Medicine Associates, LLC., Skokie
AMR-Baber Research Inc., Naperville
St. Charles Psychiatric Associates - Midwest Research Group, Saint Charles
Heartland Research Associates, LLC, Wichita
Louisiana Research Associates, Inc., New Orleans
Lake Charles Clinical Trials, Lake Charles
Louisiana Clinical Research, LLC, Shreveport
Arkansas Psychiatric Clinic Clinical Research Trials, P.A., Little Rock
IPS Research, Oklahoma City
Cutting Edge Research Group, Oklahoma City
InSite Clinical Research, DeSoto
FutureSearch Trials of Dallas, L.P., Dallas
University of Texas (UT) Southwestern Medical Center at Dallas, Dallas
FutureSearch Trials, Austin
Radiant Research, Inc., Denver
Radiant Research, Inc, Salt Lake City
University of Utah School of Medicine Department of Psychiatry Mood Disorders Clinic, Salt Lake City
Southwestern Research Incorporated, Beverly Hills
Synergy Clinical Research Center, National City
Artemis Institute for Clinical Research, San Diego
Collaborative Neuroscience Network, Inc., Garden Grove
Summit Research Network (Oregon), Inc., Portland
Comprehensive Psychiatric Care, Norwich
William B. Backus Hospital Satellite Blood Draw, Norwich
Massachusetts General Hospital, Boston
AccelRx Research, Fall River
Center for Emotional Fitness, Cherry Hill
Lincoln Research, Lincoln
University of Texas (UT) Southwestern Medical Center at Dallas, Dallas
Virginia Commonwealth University (VCU) Medical Center, Richmond
Lead Sponsor
Pfizer
INDUSTRY